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Abstract
Introduction and hypothesis In a retrospective study, the
sacrospinous hysteropexy was associated with a shorter
recovery time compared to a vaginal hysterectomy with no
differences in anatomical outcomes. No randomized trials
are performed.
Methods Sixty-six women with stage2–4 uterine descent
were randomized for vaginal hysterectomy(31) or sacrospi-
nous hysteropexy(35). Recovery time, anatomical out-
comes, functional outcomes, and quality of life were
measured.
Results Length of time to return to work was shorter after a
sacrospinous hysteropexy (43 versus 66 days, p=0.02). The
difference in risk for recurrent prolapse stage2 or more of
the apical compartment at 1-year follow-up was 17% (95%
confidence interval, 2 to 30) in favor of the vaginal
hysterectomy. No differences in quality of life and
urogenital symptoms were found.
Conclusions The sacrospinous hysteropexy for uterine
descent is associated with an earlier recovery time, more
recurrent apical prolapses but no differences in functional
outcomes, and quality of life.
Keywords Anatomicaloutcomes.Pelvicorganprolapse.
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Introduction
Pelvic organ prolapse is a major health problem that will
increase in the next decennia due to increased life
expectancy. In 1989, Richardson reported on the sacrospi-
nous hysteropexy, a procedure performed in case of a
uterine descent, in which the uterus could be preserved [1].
Today, it is unclear whether removing the uterus is
necessary or leads to better results. In several studies, it
has been shown that sacrospinous hysteropexy is anatom-
ically efficient and safe, and most women have been highly
satisfied with the procedure [1–6]. In only three non-
randomized studies, the sacrospinous hysteropexy was
compared with a vaginal hysterectomy in terms of
anatomical outcomes [4–6]. The procedures were equally
effective with regard to anatomical outcomes. Recovery
time after a sacrospinous hysteropexy has been shown to be
significantly shorter compared to vaginal hysterectomy in a
retrospective study [4]. The only randomized study ever
performed involving sacrospinous hysteropexy and vaginal
hysterectomy focused solely on sexual function 6 months
after surgery [7].
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DOI 10.1007/s00192-009-1014-7A recent editorial comment in this journal concluded that
“no proper randomized trial of hysterectomy versus non-
hysterectomy in uterine prolapse repair has yet been done
(and certainly, will not be easy to do”)[ 8].
We performed a randomized study comparing the
vaginal hysterectomy with the sacrospinous hysteropexy
for the treatment of uterine descent stage2–4i nw o m e n
with no medical history of pelvic surgery and with a
normal uterus, cervix, and ovaries and compared differ-
ences in recovery time. Also, data on recurrent prolapse
stage2–4, recurrent prolapse surgery, functional out-
comes, and quality of life at 1-year follow-up are
presented.
Materials and methods
This nonblinded, randomized study was approved by the
ethics committees of the six participating hospitals (Uni-
versity Center Utrecht, Meander Medical Center Amers-
foort, Rijnstate Hospital Arnhem, St. Antonius Hospital
Nieuwegein, St. Elisabeth Hospital Tilburg, and Twee
Steden Hospital Tilburg).
Patients
Women were referred to one of the hospitals by their
general practitioner because of symptomatic pelvic organ
prolapse. Between February 1, 2004 and December 1,
2006, women were invited to participate. Criteria for
entry into the study were the presence of a uterine
descent stage2–4 according to the classification of the
International Continence Society and the patient’sd e s i r e
for surgical correction [9]. Other selection criteria were no
medical history of pelvic surgery, normal uterus and
ovaries on ultrasound examination, normal menstrual
bleeding pattern (if premenopausal), normal cervical
cytology, and no insulin-dependent diabetes mellitus.
After informed consent, patients were randomly assigned
by drawing sealed and opaque envelopes for one of the
two types of prolapse surgery. Randomization was
centralized. The gynecologist contacted the research nurse
or the principal investigator when randomization was
needed. The gynecologist was informed about the surgical
procedure by phone and mail.
Measurements
Primary outcome of the study was recovery time after
surgery including return to daily activities and resumption
of work activities. Secondary outcomes were complica-
tions, anatomical outcomes, functional outcomes, and
quality of life at 1-year follow-up.
Baseline characteristics were collected. All women were
asked to complete a diary considering recovery time and
when applicable, returning to work.
Postoperative pain management in each hospital was
done according to the protocol. Information about
complications during and after surgery and length of
hospital stay were collected in the clinical research file of
all study participants. All women were counseled the
same about restrictions at home and at work. No heavy
lifting, heavy house chores, exercise, and work was
allowed in the first 6 weeks. At baseline and 1 year after
surgery, women underwent pelvic examination using the
pelvic organ quantification system (POP-Q) [9]. We
compared the recurrence rate stage2–4o ft h ea p i c a l ,
anterior, and posterior compartment after a vaginal
hysterectomy and sacrospinous hysteropexy. A prolapse
stage2–4 on gynecological examination 1 year after
surgery was considered a recurrence. The necessity for
repeat surgery was indicated by the treating gynecologist.
Functional outcomes and quality of life were measured
with the urinary distress inventory (UDI) and the inconti-
nence impact questionnaire (IIQ) before surgery and 1 year
after surgery, which was translated and validated for the
Dutch population [10]. The scores of these domains vary
between zero and 100. A high score on a particular domain
indicates more bothersome symptoms or the worst quality
of life.
Surgical procedures
Experienced gynecologists from the six participating
hospitals performed all vaginal hysterectomy procedures.
Sacrospinous hysteropexy procedures were performed by
experienced gynecologists with special skills in pelvic floor
surgery who had performed at least 20 sacrospinous
hysteropexy procedures before the start of the study. The
vaginal hysterectomy and sacrospinous hysteropexy were
combined with an anterior or posterior colporrhaphy (fascia
plication) or both with absorbable Vicryl 2-0 interrupted
sutures (Ethicon, Sommerville, New Jersey, USA) when
indicated by the judgment of the individual gynecologist. In
the vaginal hysterectomy group, the uterosacral ligaments
were reattached with resorbable sutures (Vicryl 1, Ethicon,
Sommerville, New Jersey, USA) to the vaginal cuff after
removal of the uterus [11].
The sacrospinous hysteropexy was performed unilater-
ally to the right ligament. A midline incision in the
posterior vaginal wall was extended to the posterior part
of the cervix. In two women, a transverse incision was
made 2 cm below the fornix posterior because of the
preference of the surgeon. Through sharp and blunt
dissection, the right sacrospinous ligament was made
visible with the use of three Breisky retractors. Two
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New Jersey, USA) were placed through the right sacrospi-
nous ligament, approximately 2 cm medial to the ischial
spine, and subsequently, placed through the posterior side
of the cervix in the midline. The cervix was placed in close
contact with the ligament without a suture bridge. In case of
coexisting urinary stress incontinence, a surgical procedure
using tension-free vaginal tape (Ethicon, Sommerville, New
Jersey, USA) was performed retropubic as described by
Ulmsten.[12]. All women received perioperative thrombo-
sis prophylaxis and a single dose of intravenous prophy-
lactic antibiotic before surgery. Postoperatively, an
indwelling bladder catheter was placed in all women and
removed 24 h after surgery (except after an additional
anterior colporrhaphy, in which case it was left in place for
3 days).
Sample size calculation
The sample size was calculated for the primary outcome
measurement, recovery time. With an expected difference
between groups of 25% (68% fully recovered within
3 months after a sacrospinous hysteropexy and 43% after
a vaginal hysterectomy in a previous retrospective study)
[4], a power of 80%, and an alpha of 0.05; at least 61
women in each group were needed to be enrolled.
Statistical analysis
An intention to treat analysis was performed to calculate
which of the two surgical procedures scored best with
respect to the outcome measurements and to calculate the
difference in risk and corresponding 95% confidence
intervals of recurrent prolapse. Descriptive statistics were
used for continuous (means and standard deviation) and
categorical (numbers/percentages) data. Differences
between the groups were analyzed with an unpaired
Student’s t test for continuous variables and the chi-square
test for categorized variables. Before and after surgery,
domain scores on functional outcomes and quality of life
were calculated with a paired Student’s t test. A regression
analysis was performed to correct age. A p value of <0.05
was considered significant.
To handle the problem of missing data on POP-Q stage,
we calculated two different scenarios. First, we used data
on POP-Q stage of the last gynecological examination
available, known as the last observation carried forward
method [13]. Second, we used the worst-case scenario
method in which all women who were not seen for
gynecological examination 1 year after surgery were
regarded as having a recurrent prolapse stage4 on all
compartments. All statistical analyses were performed
using confidence interval analysis and SPSS [14].
Results
Seventy-one women with symptomatic uterine descent
stage 2–4 requiring surgery were randomized between
February 2004 and December 2006. A trial profile of
subject enrollment is displayed in Fig. 1. After randomiza-
tion and before surgery, five women withdrew from further
participation. In three of these five women, surgery was
cancelled because the women stated that their complaints
decreased. One woman was diagnosed with atypical
endometrial hyperplasia after a diagnostic workup and
therefore, was treated differently. One woman refused to
participate because answering the questionnaires was
regarded as too much of a bother. In the remaining 66
women, there were six protocol deviations; two women
underwent a vaginal hysterectomy instead of a sacrospi-
nous hysteropexy (one woman because of inadequate
visualization of the sacrospinous ligament, and in one
woman, the reason for changing the procedure was not
written down adequately in the clinical research file); and
four women had an exclusion criterion that was over-
looked before randomization. Two of them were diag-
nosed with insulin-dependent diabetes mellitus (one in
each group) and two of them had a medical history of
pelvic surgery (one in each group, cesarean delivery, and
posterior colporrhaphy).
Not all women returned the diary and/or questionnaires
(see Fig. 1) for a variety of reasons but mostly because this
was too much of a bother. All these women, except for one,
were contacted at 1-year follow-up and reported no
symptoms except for recurrent stress incontinence (n=1).
Two women of the sacrospinous hysteropexy group did
not return for a gynecological examination at 1-year follow-
up. One woman was lost to follow-up 6 weeks after surgery
for unknown reasons. The other woman was only examined
at 6-month follow-up. None of these women had returned
to their hospital or general practitioner because of recurrent
prolapse symptoms at 1-year follow-up.
Table 1 shows the baseline characteristics of the 71
randomized women and the surgical procedures performed
in the 66 analyzed women. The baseline table shows no
incomparability in the patient characteristics in the two
groups, except age. The mean age of women who
underwent a vaginal hysterectomy was about 2 years higher
than the mean age of women who underwent a sacrospi-
nous hysteropexy.
In both groups, no bladder or rectal injuries occurred; no
blood transfusions or intensive care admissions were
needed. Five days after surgery, one woman who under-
went a vaginal hysterectomy was diagnosed with a distal
occlusion of the right ureter. A nephrostomy catheter was
placed that relieved the pain symptoms, and the patient
was treated with antibiotics. At a 4-month follow-up,
Int Urogynecol J (2010) 21:209–216 211normal ureter function returned, and the patient recovered
completely.
In Table 2, hospital stay and time returning to working
activities are shown. Women returned to work 23 days
earlier after a sacrospinous hysteropexy compared with
women after a vaginal hysterectomy.
In Table 3, the mean total vaginal length (TVL) and
point C, D, Ba, and Bp of the POP-Q in both groups is
summarized. Women who underwent a sacrospinous hys-
teropexy had a higher mean TVL 1 year after surgery. Also,
point D was significantly higher. In some women, only
POP-Q stage was written down in the clinical research file.
This explains the number of missing data in Table 3.
In Table 4, the stages of pelvic organ prolapse 1 year
after surgery are shown. The data at 1-year follow-up
include the anatomical outcome of three women after a
sacrospinous hysteropexy who already underwent repeat
surgery because of recurrent prolapse (two of these three
because of apical prolapse). This means that at 1-year
follow-up, 7+2 women (9/34, 27%) had recurrent uterine
descent stage2 or more. Three women who underwent a
sacrospinous hysteropexy had a stage4 prolapse before
surgery. All these women were diagnosed with a recurrent
uterine descent within 1 year. Two of these women
underwent repeat surgery.
Repeat surgery for prolapse after a sacrospinous hyster-
opexy was performed in 11% (4/35) of patients (vaginal
hysterectomy and/or colporrhaphy anterior). Surgery for
prolapse after a vaginal hysterectomy occurred in 7% (2/31)
of patients (colporrhaphy anterior and posterior; risk
difference, 5%; 95% CI=−9 to 19).
In Table 5, domain scores (scale from 0 to 100) of the
UDI and IIQ are shown before and 1 year after surgery,
according to surgical approach. No statistical differences in
domain scores were found between the surgical procedures
before surgery and 1 year after surgery. Both procedures
showed an improvement in symptoms in all domains of the
UDI and IIQ at 1-year follow-up. These improvements
were statistically significant except for the obstructive
micturition domain, which was of borderline significance
(p=0.06) in the sacrospinous hysteropexy group. In the
vaginal hysterectomy group, there was no statistically
513 women with 
uterine descent 
stage 2-4 wanting 
operative correction 
104 met exclusion 
criteria 
 
338 refused 
participation, 
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sacrospinous 
hysteropexy 
31 vaginal 
hysterectomy 
 
1 withdrew consent 
before surgery (too 
much bother) 
 
2 no surgery 
because complaints 
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35 sacrospinous 
hysteropexy 
1 hyperplasia of 
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because 
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decreased 
31 gynecological 
examination 
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33 gynecological 
examination 
 
31 questionnaires 
1-year  
follow-
up 
Fig. 1 Trial profile
212 Int Urogynecol J (2010) 21:209–216significant improvement in the urinary incontinence domain
(p=0.2).
Adjusting for age did not alter our findings as described
before. Also, analyzing the outcome measurements per
protocol did not influence the results outlined except for the
differences in median hospital stay (3 versus 4 days, p=
0.09 in favor of the sacrospinous hysteropexy).
Discussion
This multicenter, randomized study showed that the median
length of hospital stay and the length of time to return to
work were significantly shorter after a sacrospinous
hysteropexy as compared to the vaginal hysterectomy. The
two procedures are comparable with respect to complication
rate and functional outcomes and quality of life at 1-year
follow-up. Women who underwent a vaginal hysterectomy
for uterine descent stage2 or more had considerably fewer
recurrences (3%) of the apical compartment compared to
women after a sacrospinous hysteropexy (27%). Especially
high recurrence was noted in the preoperative high grade
prolapsepatientswhounderwenta sacrospinous hysteropexy.
Significant differences were found between the two
groups with regard to the resumption of work activities.
In a retrospective study comparing a vaginal hysterectomy
with a sacrospinous hysteropexy, women were asked about
the length of time to complete recovery after surgery [4].
After a vaginal hysterectomy, 57% of women needed more
than 3 months to recover compared with 32% of women
after a sacrospinous hysteropexy, which was a statistically
significant difference. In our study, both groups needed
almost 34 days to resume daily activities, which was also
reported by Maher et al. [5]. No other studies comparing
the vaginal hysterectomy and sacrospinous hysteropexy
were available with data on recovery time. When women
were specifically asked about returning to work activities,
the women in the vaginal hysterectomy group needed
significantly more time (23 days). The differences in
surgical techniques could be responsible for a shorter
recovery time after a sacrospinous hysteropexy. We did
not ask why women after a vaginal hysterectomy needed
more time to recover and go back to work, and we also did
not ask about the type of work. This can be regarded as a
shortcoming of the study. It appears that the differences in
recovery time are also reflected in the median length of
hospital stay, which was 1 day shorter after a sacrospinous
hysteropexy. Aside from the differences in surgical tech-
niques, other factors also have to be considered. It is
Table 1 Baseline characteristics of the women at randomization,
POP-Q, and surgical procedures performed
Sacrospinous
hysteropexy
(n=37)
Vaginal
hysterectomy
(n=34)
Age (mean±SD) 61.5±9.6 63.7±9.0
Body mass index
(mean± SD)
26.3±3.2 25.9±2.9
Parity [median (range)] 2 [0–5] 2 [1–7]
Postmenopausal 33 (89) 32 (94)
Prior surgery
Appendectomy 4 (11) 5 (15)
Sterilization 4 (11) 4 (12)
Hemicolectomy (colon
carcinoma)
1 (3) 0 (0)
Relevant comorbidity
Insulin-dependent diabetes
mellitus
1 (3) 1 (3)
Noninsulin-dependent
diabetes mellitus
1 (3) 2 (6)
Chronic obstructive
pulmonary disease
3 (8) 3 (9)
Rheumatoid arthritis 0 (0) 2 (6)
Stage of prolapse before surgery (POP-Q)
Uterine descent: stage2–4 37 (100) 34 (100)
Cystocele: stage0–1 3 (8) 2 (6)
Stage2–4 34 (92) 32 (94)
Rectocele: stage0–1 14 (38) 18 (53)
Stage2–4 23 (62) 16 (47)
Surgical procedures
performed
(n=35) (n=31)
Sacrospinous hysteropexy 33 (94) 0 (0)
Vaginal hysterectomy 2 (6) 31 (100)
Anterior colporrhaphy 28 (80) 31 (100)
Posterior colporrhaphy 20 (57) 15 (48)
Tension-free vaginal tape 4 (11) 3 (10)
Data are presented as n (%) unless otherwise noted
SD standard deviation Table 2 Hospital stay and recovery time according to surgical
approach
Sacrospinous
hysteropexy
(n=35)
Vaginal
hysterectomy
(n=31)
p
value
Hospital admission (days):
Median (range) 3 (3–7) 4 (3–14) 0.03
a
Recovery time (days) (n=29) (n=28)
• Return to daily
activities
34 (13) 33 (21) 0.9
• Return to working
activities
43 (21) 66 (34) 0.02
• Completely return to
work
57 (33) 80 (45) 0.08
Data are means (standard deviation)
p values calculated with independent Student’s t test
ap value was calculated with Mann–Whitney U test
Int Urogynecol J (2010) 21:209–216 213possible that the doctor released women earlier after a
sacrospinous hysteropexy because this procedure was
considered less complex. Also, women might have felt that
after a sacrospinous hysteropexy, recovery time would be
shorter because surgery appeared less invasive to them.
However, all women were counseled the same way about
recovery time after surgery; so, we do not think this had a
major influence on the outcome. Although this study was
not performed to evaluate the costs of these operations, the
results could be of economic importance.
In the literature, only a few studies describe functional
outcomes after a sacrospinous hysteropexy [2–6]. Validated
questionnaires were used in three studies, all with a
retrospective design [2–4]. In only one of these studies
were preoperative functional outcomes described. Our
domain scores were comparable to the domain scores in
these studies. Roovers et al. also used validated question-
naires in a study comparing a vaginal hysterectomy for
uterine descent with an abdominal approach [15]. The
domain scores on urogenital symptoms and quality of life
were comparable to our results after a vaginal hysterecto-
my. In all of these studies, a large improvement in prolapse
symptoms was shown. The impact on urinary symptoms
was smaller, but we can conclude that both procedures
provided significant improvement in urogenital symptoms
and quality of life. However, because the vaginal hysterec-
tomy and the sacrospinous hysteropexy were performed
concomitantly with an anterior colporrhaphy in (almost) all
cases, we do not know which surgical procedure contrib-
uted the most to the improvement in urogenital symptoms.
Anatomical recurrences of the apical compartment after
a sacrospinous hysteropexy are described in 0% to 15% of
patients [16]. After a vaginal hysterectomy for uterine
descent, recurrences of the apical compartment varied
between 0% and 12% [16]. It should be noted that almost
all of these studies were nonrandomized.
An explanation for the variety of recurrence rates in the
literature is the heterogeneity of data collection. Most
studies were retrospective and based on medical files, not
on gynecological examinations performed and regardless of
symptoms. The rate of recurrent surgery for apical prolapse
was low in all studies (0–7% for a vault prolapse and 0–5%
for a recurrent uterine descent) [16]. Recurrences of the
anterior, posterior, and apical compartment after a vaginal
hysterectomy in our study were comparable to that of
Roovers et al. [15]. Compared with nonrandomized
prospective and retrospective studies, our recurrence rates
Table 4 Stage of prolapse 1 year after surgery according to surgical
approach
1year after surgery Sacrospinous
hysteropexy
(n=34)
Vaginal
hysterectomy
(n=31)
Difference
(95% CI)
p
value
LOCF n (%) n (%) %
Uterine
descent/
stage
0–1
27 (79)
a 30 (97) 17 (2–32) 0.03
vaginal vault
descent
stage
2–4
7 (21) 1 (3)
Cystocele stage
0–1
17 (50) 11 (35) −15
(−38–9)
0.2
stage
2–4
17 (50) 20 (65)
Rectocele stage
0–1
28 (82) 22 (71) −11 (−32–
9)
0.3
stage
2–4
6 (18) 9 (29)
Worst-case scenario (n=35) (n=31)
Uterine
descent/
vaginal
vault
descent
stage
0–1
26 (74)
a 30 (97) 23 (7–38) 0.01
stage
2–4
9 (26) 1 (3)
Cystocele stage
0–1
17 (49) 11 (36) −13
(−37–11)
0.3
stage
2–4
18 (51) 20 (64)
Rectocele stage
0–1
27 (77) 22 (71) −6( −27–
15)
0.6
stage
2–4
8 (23) 9 (29)
LOCF last observation carried forward
aIn this group of women, two women had recurrent surgery for apical
prolapse
Table 3 Pelvic organ prolapse quantification system: point C, D, Ba,
Bp, and TVL before surgery and 12 months after surgery
Sacrospinous
hysteropexy
(n=30)
Vaginal
hysterectomy
(n=27)
Difference
(95%CI)
p
value
Before
surgery
n (SD) n (SD)
• TVL 8.1 (0.9) 7.8 (1.0)
• C 1.5 (2.1) 1.6 (2.8)
• D −1.3 (4.2) −0.7 (5.3)
• Ba 1.8 (2.3) 2.2 (2.1)
• Bp −1.0 (2.1) −0.1 (3.5)
1 year after
surgery
(n=30) (n=29)
• TVL 8.8 (1.3) 7.3 (1.5) 1.5 (0.7–
2.2)
<0.01
• C −5.1 (3.6) NA NA NA
• D −7.4 (2.6) −5.7 (1.9) −1.7 (−2.9–
−4.4)
0.01
• Ba −1.1 (1.9) −0.7 (1.5) −0.5 (−1.3–
0.4)
0.4
• Bp −2.2 (1.2) −2.0 (1.3) −0.2 (−0.9–
0.4)
0.5
Data are numbers (standard deviation)
NA not available
214 Int Urogynecol J (2010) 21:209–216of the apical compartment after the sacrospinous hyster-
opexy at 1-year follow-up were high. The number of
women with and without a recurrent uterine descent was
too small to make a statistical subanalysis. We did found
that all women with a preoperative prolapse stage4 had a
recurrent apical prolapse after a sacrospinous hysteropexy.
Two of these women underwent recurrent surgery. Lin et al.
described a correlation between a high rate (75%) of
recurrent prolapse and a stage3 or 4 prolapse preoperatively
[17]. Based on their data, they advised against performing a
sacrospinous hysteropexy in case of a stage3 or 4 uterine
descent. In our study, 44% of women who underwent a
sacrospinous hysteropexy had a stage3 or 4 uterine descent.
This could have also influenced our recurrence rates. It
could be that when the uterus is situated outside the vagina
for a long time, the cervix becomes more fragile and
erosive. This might be a risk factor for tearing the suture out
of the cervix. In most reports on the sacrospinous
hysteropexy, only a selected group of women (no stage3
or 4 uterine descent) were included into the study [5, 6]
Therefore, these studies are not comparable to our study.
Recurrent uterine descent was already present at 6 months
follow-up. After 6 weeks, women were instructed to expand
their activities (but still not to perform heavy lifting).
Possibly, after expanding activities, the Prolene sutures
were torn from the cervix. Apical prolapse after a vaginal
hysterectomy is, probably, based on stretching of the tissue
(sacrouterine ligaments) over time and as a consequence,
develop over time and therefore, were less found in our 1-
year follow-up. In the literature, it was stated that after a
sacrospinous hysteropexy is performed, the vaginal axis
would become more horizontal with a higher risk of
developing a cystocele [18]. Smilen et al. could not confirm
this hypothesis [19]. Although we agree that the vaginal
axis will be different, we also did not find more cystoceles
after a sacrospinous hysteropexy is compared with a
vaginal hysterectomy at 1-year follow-up.
Thestrength ofourstudywas therandomization thatmade
the two groups of women comparable. Thereby, in contrast to
other comparative studies between the sacrospinous hyster-
opexy and the vaginal hysterectomy, we focused on recovery
time, anatomical outcomes, functional outcomes and quality
of life, and validated questionnaires were used [10].
We chose to perform a multicenter study to make the
group of gynecologist who performed the surgery more
generalizable compared with a 1-center study. This also can
be of influence on the results of the outcomes because more
different surgeons will also bring about more differences in
experiences of the surgical techniques. We tried to avoid
this by having a minimum of 20 procedures performed by
the responsible gynecologist before the start of the study.
Some limitations need to be addressed. The number of
subjects fell short of the sample size that was calculated. As
mentioned in the methods section, the sample size was
calculated for postoperative recovery time, not for differ-
ence in functional outcomes. Unfortunately, many women
were reluctant to let a lottery decide whether their uterus
was to be removed. This is reflected in our study flow chart
(Fig. 1). Only 17% of the potential 409 women participated.
A lot of women had a preference for one of the two
Table 5 Domain scores of the urinary distress inventory (UDI) and incontinence impact questionnaire (IIQ) before and after surgery according to
surgical approach
Before surgery 1year after surgery
SSH, n=34 VH, n=31 SSH, n=31 VH, n=27 Difference (95% CI) p value
UDI domain scores:
Overactive bladder 22 (20) 25 (24) 11 (18) 12 (17) 0.5 (−10.1–11.1) 0.9
Urinary incontinence 11 (14) 10 (16) 6 (8) 6 (11) 0.3 (−4.8–5.4) 1.0
Obstructive micturition 11 (19) 23 (26) 3 (9) 8 (16) −5.0 (−13.6–3.6) 0.1
Genital prolapse 55 (30) 64 (32) 2 (5) 4 (13) −2.5 (−7.9–2.9) 0.5
Pain 22 (19) 24 (25) 11 (18) 7 (21) 2.5 (−7.3–12.4) 0.4
IIQ domain cores:
Physical functioning 17 (23) 23 (23) 3 (9) 12 (22) −9.9 (−18.5–−1.3) 0.06
Mobility 20 (18) 26 (17) 7 (13) 12 (15) −3.6 (−10.5–3.3) 0.3
Emotional health 13 (15) 12 (19) 5 (8) 6 (11) −2.0 (−6.9 – 3.0) 0.5
Social functioning 6 (12) 14 (18) 2 (7) 3 (8) −0.9 (−4.7 – 2.8) 0.6
Embarrassment 10 (14) 16 (14) 4 (11) 6 (16) −2.6 (−9.4 – 4.2) 0.5
Data are numbers (standard deviation)
SSH sacrospinous hysteropexy, VH vaginal hysterectomy
UDI, 0=not bothersome and 100=most bothersome
IIQ, 0=best quality of life and 100=worst quality of life
Int Urogynecol J (2010) 21:209–216 215procedures. These women could be divided into two groups.
When women were told that at the time of the study we did
not know whether one procedure was superior to the other,
some chose to retain their uterus (“why remove the uterus if
not necessary?”). Another group of women wanted to have
their uterus removed because family members or friends had
good experience with this procedure (first choice operation
for decades). Thereby, some women think that when the
uterus is removed, prolapse cannot occur anymore. Also, the
fact that a removed uterus cannot give any health problems
(cancer of the cervix or uterus) in future times could be a
reason to prefer a vaginal hysterectomy. We do not think that
thestage of prolapse or differences in symptoms was a reason
for preferring one of the two procedures. Therefore, our
results are most likely generalizable to all patients who meet
the inclusion and exclusion criteria. If randomization were
performed just before surgery or even in the operating room,
fewer protocol violations would have occurred. However, we
had chosen to randomize earlier to have more time to inform
women about the procedure they were randomized to.
Based on the results of this study, a sacrospinous
hysteropexy for the correction of uterine descent stage2–4i s
associated with earlier return to work activities with no
differences in quality of life and functional outcomes. Based
on the anatomical results at 1-year follow-up, the vaginal
hysterectomy had fewer recurrences in the whole group of
high and low grade prolapse compared to the sacrospinous
hysteropexy. A stage4 prolapse preoperative was associated
with a high recurrence rate of uterine descent after a
sacrospinous hysteropexy with the need for recurrent surgery.
Longer follow-up data will follow. A large cohort study will
be needed to search for risk factors for having anatomical
recurrent prolapse after a sacrospinous hysteropexy.
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